Nisa Investment Advisors, LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Nisa Investment Advisors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	BUY	$83.14 - $145.99 $57,366 - $100,733	690 Added 18.64%	4,392 $640,000
Q1 2022 Apr 29, 2022	BUY	$110.08 - $142.92 $112,391 - $145,921	1,021 Added 38.08%	3,702 $439,000
Q4 2021 Feb 03, 2022	BUY	$99.73 - $148.48 $60,935 - $90,721	611 Added 29.52%	2,681 $356,000
Q4 2020 Jan 25, 2021	BUY	$65.07 - $98.24 $16,267 - $24,560	250 Added 13.74%	2,070 $177,000
Q3 2020 Oct 20, 2020	BUY	$59.04 - $77.95 $75,571 - $99,776	1,280 Added 237.04%	1,820 $118,000
Q2 2020 Jul 27, 2020	SELL	$29.01 - $74.23 $15,085 - $38,599	-520 Reduced 49.06%	540 $39,000
Q1 2020 Apr 17, 2020	SELL	$27.51 - $57.29 $7,840 - $16,327	-285 Reduced 21.19%	1,060 $36,000
Q4 2019 Jan 17, 2020	BUY	$40.86 - $57.65 $10,010 - $14,124	245 Added 22.27%	1,345 $73,000
Q3 2019 Oct 17, 2019	BUY	$37.38 - $49.47 $34,389 - $45,512	920 Added 511.11%	1,100 $46,000
Q3 2018 Oct 16, 2018	BUY	$32.79 - $43.0 $5,902 - $7,740	180 New	180 $7,000

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Nisa Investment Advisors, LLC with notifications on news.